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Summary
Objective: Regardless of recent progress in the elucidation of intervertebral disc (IVD) degeneration, the basic molecular characteristics that
deﬁne a healthy human IVD are largely unknown. Although work in different animal species revealed distinct molecules that might be used as
characteristic markers for IVD or speciﬁcally nucleus pulposus (NP) cells, the validity of these markers for characterization of human IVD cells
remains unknown.
Design: Eleven potential marker molecules were characterized with respect to their occurrence in human IVD cells. Gene expression levels of
NP were compared with annulus ﬁbrosus (AF) and articular cartilage (AC) cells, and potential correlations with aging were assessed.
Results: Higher mRNA levels of cytokeratin-19 (KRT19) and of neural cell adhesion molecule-1 were noted in NP compared to AF and AC
cells. Compared to NP cytokeratin-18 expression was lower in AC, and alpha-2-macroglobulin and desmocollin-2 lower in AF. Cartilage olig-
omeric matrix protein (COMP) and glypican-3 expression was higher in AF, while COMP, matrix gla protein (MGP) and pleiotrophin expression
was higher in AC cells. Furthermore, an age-related decrease in KRT19 and increase in MGP expression were observed in NP cells. The age-
dependent expression pattern of KRT19 was conﬁrmed by immunohistochemistry, showing the most prominent KRT19 immunoreaction in the
notochordal-like cells in juvenile NP, whereas MGP immunoreactivity was not restricted to NP cells and was found in all age groups.
Conclusions: The gene expression of KRT19 has the potential to characterize human NP cells, whereas MGP cannot serve as a characteristic
marker. KRT19 protein expression was only detected in NP cells of donors younger than 54 years.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Degeneration of the intervertebral disc (IVD) and related
spinal disorders are leading causes of morbidity, resulting
in substantial pain, disability and increased health care
costs1. The IVD comprises the highly hydrated nucleus pul-
posus (NP), the surrounding multilaminar annulus ﬁbrosus
(AF) and the cartilaginous endplates. Pathophysiological
evidence indicates that IVD degeneration starts in the NP,
where the concentration of proteoglycans and the synthesis
of type II collagen decrease2,3. At the same time denatur-
ation of type II collagen ﬁbers and synthesis of type I colla-
gen occurs3. As a consequence the NP loses its osmotic
properties and becomes ﬁbrotic; the disc loses its ability
to transmit intervertebral forces and further degenerative
processes may occur.
Regeneration of NP tissue in the early stages of degener-
ation may slow down or even reverse the degenerative pro-
cesses and might possibly restore part of the degenerated*Address correspondence and reprint requests to: Sibylle Grad,
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416disc. Thus, regenerative medicine and biological therapies
hold great promise. In particular the therapeutic implications
of stem cells have been highly anticipated by both the clin-
ical and scientiﬁc communities4,5. The challenge in charac-
terizing cellular degeneration and ultimately accomplishing
cellular regeneration begins with the identiﬁcation of the
molecular phenotype of the cells that constitute the NP.
The NP includes small cells commonly referred to as ‘‘chon-
drocyte-like’’, since they have a similar rounded morphology
and synthesize similar extracellular matrix macromolecules
as articular chondrocytes. Currently, no reliable markers ex-
ist to distinguish NP cells from the chondrocytes from hya-
line cartilage. A cell population with the properties of
articular cartilage (AC) would fail to restore the necessary
function of the IVD because the requisite ﬂuid properties
unique to the IVD would not be recreated. While the ratio
of proteoglycan to collagen shows a certain potential to sep-
arate disc cells, recent research has focused on the clariﬁ-
cation of their molecular phenotype6. In a recent study, rat
NP cells were compared with cells from the AF and AC tis-
sues by means of large scale microarray gene expression
screening. Subsequent quantitative gene expression and
immunohistochemical analyses identiﬁed distinct mole-
cules, namely glypican-3 (GPC3) and cytokeratin-19
417Osteoarthritis and Cartilage Vol. 18, No. 3(KRT19), as promising candidates for NP cell characteriza-
tion7. Similar studies in the beagle dog revealed additional
potential NP marker molecules, including alpha-2-macro-
globulin (A2M), cytokeratin-18 (KRT18), desmocollin-2
(DSC2), and neural cell adhesion molecule-1 (NCAM1)8.
However, considerable developmental, anatomical, and
biochemical differences among species are likely to affect
the phenotypical characteristics of the disc cells9. In partic-
ular the presence of notochordal cells, which are regarded
to be remnants of the embryonic notochord, in the NP is
the cause of substantial inter-species variation. Mice, rats,
rabbits, and non-chondrodystrophoid dogs retain a predom-
inantly notochordal NP until adulthood and often throughout
life, whereas bovine, ovine and chondrodystrophoid dogs
closer resemble humans in that the number of notochordal
cells rapidly decreases after birth10. Moreover, differences
in tissue size, oxygen and nutrient supply, and biomechan-
ical requirements are also likely to affect the molecular fea-
tures of the cells in the disc. As a consequence,
observations from animal discs will not necessarily apply
to human discs. Nevertheless, animal studies are indis-
pensable for screening purposes, since they allow investi-
gation of normal healthy tissues with larger sample size
and smaller inter-individual variability. Due to the limited
availability of healthy and viable human IVD tissue, compre-
hensive screening is difﬁcult in human individuals. The aim
of this study therefore was to evaluate the presence and
distribution of the molecules that were found to be differ-
ently expressed in disc and cartilage cell populations in var-
ious animal species in human disc cells. To account for
potential variations related to aging and degeneration, cell
and tissue samples from individuals of different age groups
and disc degeneration grades were examined.Materials and methodsISOLATION OF NP, AF, AND AC CELLSThe study was approved by the medical ethical committee of the University
Medical Center (UMC) Utrecht and the scientiﬁc committee from the Depart-
ment of Pathology of the UMC Utrecht. Eleven patients with no known history
of IVD disease were included in the study. Samples were obtainedwithin an av-
erage of 17.5 h after death of the patient (range 6.25e23.0 h). The age of the
individuals ranged from 22 to 81 years (average 46 20 years; median 43
years), and the average degree of disc degeneration, assessed according to
the Thompson score11, was 2.2 1.0 (median 2) (Table I). IVD tissue was har-
vested from segments between L1 and L5 and was separated into NP and AF
tissue. To exclude any contamination by AF tissue, only the innermost part ofTable I
Patients included for gene expression analysis of NP, AF, and AC
cells. IVD tissue was harvested from discs between L1 and L5
and separated in NP and AF; AC was harvested from the patella
joint surface. Cartilage quality was macroscopically assessed and
was without detectable changes for patients 1e9. Slight degenera-
tive changes were detected in patient 10, and signs of osteoarthritis
in patient 11
Patient number Age Gender Thompson grade
1 22 M 1
2 25 M 1
3 25 M 1
4 32 M 1e2
5 40 M 2
6 43 M 2
7 46 M 2e3
8 56 M 3
9 61 F 3
10 72 M 4
11 81 F 3the disc was harvested to be assigned to NP tissue, whereas the transition
zone, including part of the inner AF, was entirely excluded from analysis. This
is of particular importance for aged discs, where it can be difﬁcult to clearly dis-
tinguish NP and AF tissues. AC was harvested from the patellae of the same
patients. Chondrocytes were extracted from full thickness cartilage which im-
plies mixed populations of superﬁcial, middle and deep zone cells. Gene ex-
pression data thus represent an average cellular expression of target mRNA.
Tissue was cut into small pieces and cells were enzymatically isolated us-
ing sequential pronase (Roche) and type II collagenase (Worthington Bio-
chemical) digestion with DNase II (Sigma) added to prevent cell clumping.
AC and AF were treated with 0.2% pronase/0.004% DNase for 1 h, then
with 200 U/mL collagenase/0.004% DNase over night. NP was treated with
0.2% pronase/0.004% DNase for 1 h, then with 100 U/mL collagenase/
0.004% DNase for 8 h, stirring at 37C in humidiﬁed atmosphere. After enzy-
matic isolation cell suspensions were ﬁltered through a 70 mm cell strainer,
washed twice with Dulbecco’s Modiﬁed Eagles Medium, and lysed in TRI
Reagent (Molecular Research Center, Cincinnati, OH). Samples were stored
at 80C until RNA isolation.RNA EXTRACTION AND REAL TIME RT-PCRRNA was isolated using a modiﬁed TriSpin method7,12. Brieﬂy, bromo-
chloro-propane (Sigma) was added to the lysate, phases were separated,
and ethanol (Merck) added to the aqueous phase. Total RNA was extracted
using the SV Total RNA Isolation System (Promega), which includes an on-
column DNAse digestion, and eluted in 100 ml of RNase-free water. TaqMan
reverse transcription reagents (Applied Biosystems, Foster City, CA) were
used for cDNA synthesis. PCR was performed with an SDS 7500 real time
PCR instrument using TaqMan Gene Expression Master Mix (all from Ap-
plied Biosystems) and standard thermal conditions (10 min 95C for polymer-
ase activation, followed by 45 cycles of 95C for 15 s and 60C for 60 s).
Primer-probe systems, purchased as Gene Expression Assays, were from
Applied Biosystems. Genes that were previously found to be differentially ex-
pressed in NP compared to AF and/or AC cells in the rat and/or chondrody-
strophoid dog were chosen for analysis (Table II)7,8,13. Expression of target
genes was normalized to the 18S ribosomal RNA as the endogenous con-
trol. Relative mRNA levels were calculated according to the 2^(delta Ct)
method and presented as log(2) transformed values14,15.IMMUNOHISTOCHEMISTRYFor histological analysis human IVD tissue was obtained as part of a stan-
dard postmortem procedure, in which a section of the lumbar and thoracic
spine is removed for diagnostic purposes. IVD samples were stored in the
UMC Utrecht Biobank of the Department of Pathology. Collection and anal-
ysis of the IVDs was approved by the medical ethical committee of the UMC
Utrecht and the scientiﬁc committee of the Department of Pathology of the
UMC Utrecht. Samples were obtained within a mean of 17.7 h after death
of the patient, 95% within 24 h after death. Between death and tissue collec-
tion the deceased patients were kept at the mortuary at 4C. From all pa-
tients the IVD between the fourth and ﬁfth lumbar vertebra (spinal motion
segment L4eL5), including the adjacent endplates, was obtained. The grade
of degeneration was scored by three individual observers using the classiﬁ-
cation of Thompson et al.11. After individual scoring the values were
averaged; outliers, i.e., differences of more than 1 Thompson grade, were
re-evaluated by the three observers at a consensus meeting.
The expression and localization of KRT19 and matrix gla protein (MGP) in
IVD tissue was evaluated in 41 human individuals aged between 3 and 86
years (average 47 25 years; median 51 years, Table III). Sagittal slices
of the motion segments were ﬁxed in formalin, decalciﬁed with Kristensen’s
solution (50% formic acid and 68 g/L sodium formiate) in a microwave atTable II
Gene expression assays used for real time PCR (from Applied
Biosystems)
Gene Assay code
A2M Hs_00163474_m1
CD24 Hs_00273561_s1
COMP Hs_00164359_m1
DSC2 Hs_00245200_m1
GPC3 Hs_00170471_m1
KRT18 Hs_01920599_gH
KRT19 Hs_00761767_s1
MGP Hs_00179899_m1
NCAM1 Hs_00169851_m1
PTN Hs_00383235_m1
VIM Hs_00185584_m1
Table III
Immunohistochemical results obtained from IVD sections from the UMC Utrecht Biobank of the Dept. of Pathology. Only discs between the
fourth and fifth human lumbar vertebra (L4eL5) were assessed. Cells were classified according to their topographical position within the disc
tissue
Patient number Age Gender Thompson grade KRT19 MGP
NP NP IAF OAF EP AOA
1 3 F 1 þþ þþþ    þþ
2 3 F 1 þþþ N/A N/A N/A N/A N/A
3 6 F 1  þþþ þþ þþ  N/A
4 14 M 1 þþþ þþþ þþ þþþ  þþþ
5 14 F 1 þþ þþþ þþþ þþþ  N/A
6 14 F 1    þþ  N/A
7 17 M 2 þþþ þþþ    þþþ
8 18 M 1 þ    N/A N/A
9 19 F 1  þþþ þþ þþ  þþþ
10 21 M 1 þþ þþþ þ þþ  þþþ
11 22 F 1 þ þþ  N/A  N/A
12 25 M 1  þþ    þþ
13 35 F 2 þþþ þþ þþþ þþþ  þþþ
14 35 M N/A  þþþ þþ þþ  þþþ
15 36 M 2  þþ þ þ  N/A
16 38 M 2  þ    þ
17 41 M 2 (þ) þþþ þ þþþ  þþþ
18 44 M 2      
19 47 F 3  þþ    
20 51 F 2  (þ)  þ  þþþ
21 51 F 2 (þ) þþ    þ
22 54 F 4 (þ) þþþ  þþþ  N/A
23 57 M 4  þþ þþ þþþ  N/A
24 59 M 4  þþþ þþ N/A  N/A
25 60 M 5  þþþ þþ þþ  þþþ
26 62 F 2      þþþ
27 62 M 5  þþþ þþþ þþþ  þþþ
28 63 M 3  þþ þ   N/A
29 67 F 5  þ N/A N/A N/A N/A
30 68 F 5  N/A N/A N/A þ þþ
31 70 M 4  þþ    þþ
32 71 M 3  þþ   N/A NA
33 72 M N/A  (*) (þ)    NA
34 72 M 5  þþþ  þþþ þ þþþ
35 73 F 3  þþþ þþþ   N/A
36 74 F 3  þþ    þþþ
37 76 M 3  þþ þþþ   þþþ
38 76 F 5  þ (þ)   þþþ
39 80 F 5  (*) þþþ þþ N/A N/A þþþ
40 82 F 4  þþ    N/A
41 86 F 4  þ    N/A
Grading scheme: (þ)¼ 1e2 positive cells; þ¼ 3e4 positive cells; þþ¼ 5e10 positive cells; þþþ¼>10 positive cells per ﬁeld of view. For
analysis a Zeiss Axioplan2 microscope equipped with a 20 objective (Neoﬂuar) and a 10 ocular was used. IAF: Inner annulus ﬁbrosus;
OAF: Outer annulus ﬁbrosus; EP: Cartilaginous endplate; AOA: Attachment of outer annulus ﬁbrosus; N/A: not available. KRT19 positive cells
were only detected in the NP and in 2 cases of severe degenerative disc changes in the EP (*).
418 J. Rutges et al.: Variations in gene and protein expression in human NP150 W and 50C for 6 h, dehydrated in graded ethanol series, and embed-
ded in parafﬁn16. Sections were deparafﬁnized, treated with 3% hydrogen
peroxide in methanol for 30 min and then with heated (95C) citrate buffer
(10 mM sodium citrate, 0.05% Tween20, pH 6.0) for 20 min for antigen re-
trieval. Then they were blocked with 5% normal horse serum for 1 h, and
were incubated with mouse monoclonal anti-KRT19 antibody (clone A53-
B/A2; cat. no. EXB-11-120, Exbio, Praha, CZ) or mouse monoclonal anti-
MGP antibody (clone 52.1C5D; cat. no. ALX-804-512, Alexis Biochemicals,
Lausen, CH) at a concentration of 5 mg/ml over night at 4C. Negative control
sections were incubated without primary antibody. Biotinylated secondary
anti-mouse antibody (dilution 1:200; Vectastain ABC-kit Elite, cat. no. PK-
6102, Vector Laboratories, Burlingame, USA) was applied, followed by
ABC complex, and chromogen development using diaminobenzidine (DAB
Kit, cat. no. SK-4100, Vector Laboratories, Burlingame, USA). Sections
were counterstained with Mayer’s haematoxylin.STATISTICAL ANALYSISDifferences in relative gene expression levels between paired NP and AF
and paired NP and AC were assessed by the Wilcoxon Signed Ranks test.Correlations between relative gene expression and age or disc degeneration
grade were determined using the Pearson correlation analysis. P< 0.05 was
considered as signiﬁcant.ResultsGENE EXPRESSIONIn both the NP vs AF and the NP vs AC comparisons,
pronounced gene expression differences were observed
for KRT19. Levels of KRT19 mRNA were constantly higher
in the NP than in both AF and AC cells, although the extent
of up-regulation varied between individuals. NCAM1 ex-
pression was also increased in NP compared to AF and
AC cells, while the expression of A2M and DSC2 was
higher in NP than in AF cells and KRT18 expression was
higher in NP than in AC cells. On the other hand, mRNA
Fig. 1. Relative mRNA expression in human NP, AF, and AC cells.
Expression levels were normalized to 18S rRNA as the endoge-
nous control. *P< 0.05 in pair-wise comparison of NP with corre-
sponding AF or AC; N¼ 9e11.
Fig. 3. Relative mRNA expression for MGP in NP cells of 11 individ-
uals between 22 and 81 years of age. Gene expression was nor-
malized to the 18S ribosomal RNA. An increase in the MGP
expression level with increasing age is noted.
419Osteoarthritis and Cartilage Vol. 18, No. 3expression levels of GPC3 and cartilage oligomeric matrix
protein (COMP) were higher in the AF compared to the
NP, whereas COMP, MGP, and pleiotrophin (PTN) were ex-
pressed more highly in the AC than in the NP cells. No dif-
ferences in vimentin (VIM) and Cluster of Differentiation 24
antigen (CD24) expression were noted between NP and AF
or AC cells (Fig. 1).
While the KRT19 expression of AC and AF cells did not
change throughout age groups, its expression in the NP
cells showed a decrease with age (P¼ 0.032; Fig. 2). How-
ever, in spite of this decrease, KRT19 was still more highly
expressed in the NP compared to the AF and AC cells even
in older individuals. A correlation between age and gene ex-
pression in NP cells was also found for MGP mRNA, which
increased with increasing age (P¼ 0.003; Fig. 3). In the AF
cells, increasing levels of PTN mRNA were noted with aging
(P¼ 0.023; data not shown). The expression of MGP in NPFig. 2. Relative mRNA expression for KRT19 in NP cells of 11 indi-
viduals between 22 and 81 years of age. Gene expression was nor-
malized to the 18S ribosomal RNA. A decrease in the KRT19
expression level with increasing age is noted.cells was also positively correlated with the degree of de-
generation (P¼ 0.007). The relation between KRT19 level
in the NP and degeneration grade was found to be almost
signiﬁcant (P¼ 0.061). No association between age or de-
generation grade and the level of expression was detected
with any of the other genes analysed. However, in agree-
ment with previous reports, there was a strong relationship
between age and degeneration grade of the disc
(P< 0.001).IMMUNOHISTOCHEMISTRYKRT19 was chosen for immunohistochemical analysis,
since this molecule showed most pronounced differences
between NP and AF or AC with respect to mRNA expres-
sion, whereas MGP was selected for analysis at the protein
level because of its apparent age- and degeneration-depen-
dent increase in the NP cells, which are of main interest in
this study.
In the NP of juvenile discs (<5 years of age), clusters of
large cells with a notochordal morphology were identiﬁed.
These cells were positive for KRT19 [Fig. 4(A)], while nei-
ther cells within the AF nor cells of the cartilaginous end-
plate revealed any positive labelling [Fig. 4(B), Table III].
In the NP of young discs with Thompson score 1 but with-
out apparent existence of notochordal cells (age range
6e25 years), KRT19 positive cells were observed in 60%
(n¼ 6/10) of the individuals. Labelling was located predom-
inantly intracellular and was limited to a small number of
cells that had a somewhat chondrocytic appearance with
no morphological evidence of a notochordal cell phenotype
[Fig. 4(C, D)]. On the other hand, the majority of healthy
adult discs did not reveal any immunoreactivity for
KRT19 [Fig. 4(E)]. In two degenerate discs however (pa-
tients with sepsis), positive cells were detected adjacent
to ﬁssures associated with degenerative changes of the
cartilaginous endplate [Fig. 4(G)]. These cells exhibited
a characteristic chondrocyte-like morphology, were located
at the border between cartilaginous endplate and NP and
were not regarded as NP cells.
The number of MGP positive cells in general was higher
than the number of KRT19 positive cells, but non labelled
Fig. 4. Immunolabelling characteristics for KRT19. (A) Cells within the NP of a 3-year-old human female label positive for KRT19. (B) No
KRT19 positive cells are detected in the inner annulus of a 21-year-old male individual. (C) A group of KRT19 positive cells in the NP of
a 14-year-old male. (D) Small group of KRT19 positive cells from the NP of a 21-year-old male (same individual as in B). (E) NP of
a 47-year-old female with Thompson grade 3. No positive labelling can be detected. (F) Control from same individual as in E. (G) 72-
year-old male donor with disc degeneration grade 4. The image shows the edge of the NP region. The cartilaginous endplate is at the bottom
of the image. Several KRT19 positive cells with a chondrocyte-like morphology can be detected. All scale bars¼ 100 mm.
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juvenile and young adult discs positive cells could be de-
tected in the NP (Table III). MGP positive cells were found
in distinct clusters of NP cells in young individuals [Fig. 5(A,
B)]. In older more degenerated discs (grade 3 and higher)
positive cells were found adjacent to clefts and cracks
[Fig. 5(D)]. Furthermore, the outer AF was often immuno-
positive [Fig. 5(E)], with a decreasing intensity towards the
inner AF [Fig. 5(F)]. Labelling was limited to the cells and
to a very small portion of the pericellular matrix in their im-
mediate vicinity. The cells and extracellular matrix of the
mineralized cartilage of the endplate often demonstrated
a positive reaction for MGP, especially at the tidemark
[Fig. 5(G, H)]. The non-mineralized cartilage of the endplate
was always negative [Fig. 5(G, H)]. The ﬁbrocartilaginous
attachment of the outer AF frequently labelled positive
[Fig. 5(I)].Discussion
Degenerative changes occurring in the IVD have been
extensively described and mechanisms, including genetic
variations that may cause a predisposition to IVD degener-
ation are being elucidated. However, the molecular proﬁle
that characterizes the normal disc, and in particular the
NP cell is still unknown. Previous investigations have sug-
gested potential markers for IVD cells and more speciﬁcally
for NP cells7,8,13,17. The present study is a further contribu-
tion to the identiﬁcation of molecules expressed in human
disc cells. It was undertaken to validate potential NP marker
molecules identiﬁed by large scale gene expressionscreening in the rat and dog for their potential use with hu-
man cells.
Looking at genes previously identiﬁed as markers for the
rat NP, the expression of KRT19 could be conﬁrmed for hu-
man cells. However, a decrease in KRT19 expression with
age was noted in the NP, while the expression in AF and
AC remained constant. As KRT19 has also been associ-
ated with notochordal cells and chordoma, its expression
in healthy adult human NP cells may be unexpected18,19.
Indeed, immunohistochemical analysis conﬁrmed its pres-
ence in cells with a notochordal phenotype and further sup-
ported the suggestion of an age-dependent expression
pattern. At the protein level, KRT19 was barely detectable
in the NP after the third decade, although mRNA expression
was still clearly measurable. Possible explanations for this
ﬁnding may include differences in the detection limit be-
tween mRNA and protein expression, instability of the
mRNA, short protein half-life, or inhibition at the transla-
tional level.
In contrast to KRT19, the expression pattern of the other
genes that had been found to be expressed more highly in
the NP than in the AC in rat specimens, including CD24,
was not conﬁrmed in human samples7,13. However, GPC3
and PTN expression proﬁles were similar to observations
in beagle dogs8. This might be related to the comparable
development of the NP with respect to cell phenotype in hu-
man individuals and chondrodystrophoid dogs, which
clearly differs from the development in rats. Looking at the
genes evaluated for the beagle dog, the human samples
generally showed a similar expression pattern, with higher
levels of KRT18, A2M, and NCAM1 in NP vs AF and/or
AC. Besides KRT19, only NCAM1 was expressed more
Fig. 5. Immunolabelling characteristics for MGP. (A) Cells within the NP of a 6-year-old human female label positive for MGP. (B) Group of
MGP positive cells in the NP of a 17-year-old male. (C) Control from same individual and same region as shown in B. (D) Small group of MGP
positive cells from the NP of a 60-year-old male individual with disc degeneration Thompson grade 5. Note that the cells are forming a cluster
like structure in the neighbourhood of a ﬁssure. (E) Outer and (F) inner annulus of a 35-year-old female with Thompson grade 2. Several pos-
itive cells can be detected. The surrounding extracellular matrix is negative. (G) Endplate cartilage from a 72-year-old male with Thompson
grade 5. Note the strong positive labelling at the tidemark (arrow) and in the calciﬁed cartilage. Cells in non-calciﬁed cartilage are all negative.
(H) Endplate cartilage from a 35-year-old female individual with Thompson grade 2. The positive labelling at the tidemark (arrow) is clearly
visible. Cartilage cells form clusters (*) but are all negative. (I) Fibrocartilaginous attachment of the outer annulus of a 35-year-old female in-
dividual (same as in H). The ﬁbrocartilage cells are arranged in characteristic rows and label positive for MGP. Scale bar in G¼ 200 mm, all
other scale bars¼ 100 mm.
421Osteoarthritis and Cartilage Vol. 18, No. 3highly in NP than both AF and AC cells in this study.
NCAM1 is an integral membrane glycoprotein that can reg-
ulate both cellecell and cellesubstrate interactions, primar-
ily through polysialic acid20,21. Although it is expressed
primarily in the nervous system, NCAM1 has been identiﬁed
in various tissues in the adult rat22. In development NCAM1
plays a signiﬁcant role in cell differentiation, including di-
verse functions in osteogenesis and chondrogenesis23.
However, the fact that NCAM1 was expressed at a low level
in all cell types analysed depreciates this molecule as a use-
ful marker for human NP cells.
The matrix protein COMP showed consistently lower ex-
pression in NP than in AF and AC cells in all species. This
differential expression of COMP in cartilage and disc adds
to earlier observations of variations in the relative amounts
of distinct matrix molecules in these two tissues6. While
COMP has been identiﬁed and localized in the IVD, its rel-
atively lower expression may reﬂect differences in themechanical properties between the NP and cartilage tis-
sues24. The main molecular functions of COMP include
binding other matrix proteins and catalyzing polymerization
of type II collagen ﬁbrils. Furthermore, COMP is reported to
prevent vascularization of cartilage and this could also be
the case in the IVD tissues25.
Commonly, work that addresses the disc cell proﬁle leads
to the conclusion that disc cells express a predominantly
chondrocytic phenotype26e28. Investigations on mature bo-
vine IVD cells agreed that NP cells produce more proteogly-
cans and less collagen than AF and cartilage cells, which is
consistent with the higher hydration of the NP tissue6,29. In
rat spinal units it was demonstrated that NP can be distin-
guished from adjacent tissues by the expression of proteins
that are synthesized in response to restriction in oxygen
and nutrient supply17. Additional studies in the rat revealed
other potentially NP speciﬁc markers7,13. However, a major
disadvantage of using rat NP is the presence of cells with
422 J. Rutges et al.: Variations in gene and protein expression in human NPa notochordal phenotype. In fact several studies have used
rat cells to explore the notochordal molecular phenotype in
the disc30,31. Therefore, results from the rat, as well as
mouse or rabbit have to be extrapolated with care to the hu-
man situation. Apart from the different developmental path-
ways of the NP cell populations the large deviations in IVD
size and thus nutrition and mechanical conditions are also
likely to inﬂuence the molecular characteristics of NP cells.
Nevertheless, the expression proﬁle of KRT19 demon-
strates that selected genes may be valuable as markers
even in different species.
When comparing the present study with previous studies
on beagles, it also has to be noted that the human samples
in this study are very heterogeneous with respect to age,
while the animals all had the same age. This may explain
the less pronounced differences between NP, AF, and car-
tilage cells in human individuals compared to the dog spe-
cies, while general trends were identical in both species.
Consequently, the age of the animal always has to be taken
into consideration for the interpretation of results from an
animal model. Moreover, although a study in the rat did
not reveal major differences in gene expression pattern be-
tween RNA extracted from isolated cells and RNA extracted
directly from the tissues, enzymatic cell isolation might have
contributed to the reduced tissue-related differences ob-
served in human specimens7. Besides, it is sometimes dif-
ﬁcult to clearly distinguish human NP from AF tissue,
especially in aged discs, which can also result in lowered
gene expression differences between NP and AF cells. In
view of these difﬁculties and the observed age-related alter-
ations, young individuals are clearly preferred for the study
of the phenotype of the healthy human NP cell.
Age-related changes have been detected regardingmatrix
composition, expression of matrix degrading enzymes, and
other processes3,6,32e34. Although differences between ag-
ing and (early) degeneration were recently described in
rabbits, a strong correlation exists between age and degen-
eration grade in human patients3,35,36, which is conﬁrmed
in this study. Thus, it is not possible to clearly separate the in-
ﬂuence of aging from that of degeneration mechanisms. Ac-
cordingly, Adams and Roughly deﬁned a degenerate disc as
one with structural failure combined with accelerated or ad-
vanced signs of aging37. This has recently been demon-
strated also for the cervical spine, where in a longitudinal
study no other factor except for age was related to the pro-
gression of degeneration38. Although cases of early disc de-
generation have been described and are of particular value
for speciﬁc investigation of degenerative processes, the
present study evaluated individuals with ‘‘natural’’ disc devel-
opment, where aging is accompanied with a certain degree
of degeneration. This is particularly reﬂected in the mRNA
expression of MGP in the NP, which strongly correlated
with both aging and degree of degeneration. MGP is
a Bone morphogenetic protein-2 (BMP-2) regulatory protein
that is known as a calciﬁcation inhibitor in cartilage and in ar-
teries39,40. Interestingly, MGP serum levels of community-
based cohorts were also elevated with increasing age and
were associated with individual risk factors for coronary heart
disease41. It was suggested that induction of MGP expres-
sion may be a feedback mechanism to prevent mineraliza-
tion of calcium deposits in the arteries41. Similarly, one
could speculate that induction of MGP in the NP may be an
attempt to prevent calciﬁcation processes that have been ob-
served in the aging disc42,43. The presence of MGP in areas
of mineralized cartilage in the endplate and in cells adjacent
to sites of degeneration would support this hypothesis. The
same is true for the expression at the ﬁbrocartilaginousattachment of the outer AF where ectopic ossiﬁcation (i.e.,
exophyte growth) would be prevented. Interestingly MGP ex-
pression in non-calciﬁed AC is restricted to the superﬁcial re-
gions in monkeys and is barely detectable in senile human
cartilage tissue44. In chondrocytic cells, both over-expres-
sion ofMGP inmaturing chondrocytes and under-expression
of MGP in proliferative and hypertrophic chondrocytes may
induce apoptosis45. As it has been reported that some cells
of the IVD may differentiate towards the hypertrophic chon-
drocyte phenotype with age, MGP might function to prevent
apoptosis in these cells46. Further studies are required to
clarify the role of MGP expressed in the disc.
The observed rise in PTN gene expression in the AF with
aging may result from a cellular attempt to restore a slowly
degrading tissue. PTN functions as a growth and differenti-
ation factor in many cell types and has been shown to in-
duce the synthesis of matrix molecules in articular
chondrocytes47. In cartilage, elevated PTN levels have
been related to both osteoarthritis and rheumatoid arthri-
tis48,49. Interestingly, an increased amount of PTN-immuno-
positive cells was observed in degenerated and in
prolapsed disc samples and was associated with vascular-
ization of diseased or damaged tissue50. Since blood ves-
sels are mostly localized in the outer AF and rarely
penetrate into deeper zones of the IVD, an increasing ex-
pression of PTN in the AF with aging would support the sug-
gestion that PTN may function as an angiogenic factor in
the degenerating IVD50. Age- or degeneration-associated
changes might become clinically useful markers to deter-
mine the ‘‘juvenileness’’ or the regenerative capacity of
IVD tissues sampled from discectomies or nucleotomies.
More extended studies will be required to validate the po-
tential of such markers to individually evaluate the most ap-
propriate treatment of an IVD disorder.
In conclusion, from a selection of NP phenotype markers
identiﬁed in animal studies, KRT19 and NCAM1 expression
were found to be more pronounced in NP than AF and AC
cells in human individuals. Whereas NCAM1 levels are rel-
atively low even in NP cells, KRT19 may be regarded as
a marker for human NP cells, being highly expressed in
NP and at signiﬁcantly lower levels in AF and AC cells.
This observation on the subject of gene expression is at
least partially reﬂected at the protein level, where KRT19
positive cells are almost exclusively identiﬁed in the NP of
juvenile and young adult discs. This suggests that KRT19
transcripts are translated into detectable amounts of protein
primarily in notochordal-like cells of juvenile NP and occa-
sionally in young chondrocyte-like NP cells. MGP is found
in a variety of human IVD tissues and thus cannot serve
as a characteristic NP marker.Conﬂict of interest
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